[ad_1] SATB2 and CDX2 are prognostic biomarkers in DNA mismatch repair protein deficient colon cancer Source link [ad_1]
[ad_1] CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression Source link [ad_1]
Intestinal regulation of suppression of tumorigenicity 14 (ST14) and serine peptidase inhibitor, Kunitz type -1 (SPINT1) by transcription factor CDX2 Source link
© 2017 Worldnews Media LLC. All Rights Reserved.